AIA launches website for global patient offerings

Share this article:
Atkins International Associates (AIA) launched a multifaceted life sciences website for marketers communicating to patients across the globe.

According to Molly Naughton, vice president at AIA, the company uses translators working from a campaign's target country, including physicians and advertising specialists, to position brands within a precise cultural context.

With larger pharmas like Merck and Johnson & Johnson, many times the creative agency has already decided how to position a particular product, but may need language services, images and layout, for example, said Naughton.

For smaller biotechs and orphan drug manufacturers unwilling to spend the money on preliminary global materials from an agency, AIA offers full-service capabilities, said Naughton.    

The new AIA website launched on August 17, and offers a suite of service offerings including clinical trials and patient recruitment, marketing research, disease awareness, e-marketing and other offerings. In June, the firm launched a YouTube video explaining the finer points of working with an agency for global messaging.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...